-
Chinese (Simplified)
-
English
-
German
-
Korean
-
Spanish
Chinese (Simplified)
English
German
Korean
Spanish
Sign up for an account to enjoy easy online shopping and instant order tracking.
Activating transcription factor 7-interacting protein 1 (ATF7IP) is a multifunctional protein involved in various cellular processes. It has been shown to interact with methylated DNA-binding domain protein 1 (MBD1) and MBD1-containing chromatin-associated factor 1 (MCAF1), also known as ATFaassociated modulator (AM) [1]. ATF7IP is implicated in the maintenance of X chromosome inactivation (XCI) through its repressive context, where it mediates MBD1-dependent transcriptional silencing by recruiting and catalytically activating the histone H3K9 methyltransferase SETDB1 [2]. Furthermore, ATF7IP contains at least two functional binding surfaces for other proteins, such as SETDB1 and MBD1, and plays a role in efficient transcriptional silencing mediated by the SETDB1 complex [3][4]. It has also been identified as a transcriptional cofactor involved in histone gene expression and cellular senescence [5]. ATF7IP is recognized as a SETDB1-interacting protein and is essential for heterochromatin formation by the HUSH complex [6]. Additionally, ATF7IP has been reported to inhibit Il2 expression, regulating Th17 responses, and is an essential cofactor in SETDB1 enzymatic activity and nuclear localization [7]. Moreover, ATF7IP is involved in the regulation of SETDB1 nuclear localization and its enzymatic activity, as well as in increasing the levels of its ubiquitinated and more enzymatically active forms [8][9]. The protein also undergoes tri-methylation by G9a/GLP, recruiting the chromodomain protein MPP8, suggesting its involvement in gene regulation [10]. Interestingly, ATF7IP's methylation partially contributes to the function of the HUSH complex, as preventing K16 methylation led to a delay in HUSH complex silencing of a virally introduced transgene [11]. References:[1] L. Liu, K. Ishihara, T. Ichimura, N. Fujita, S. Hino, S. Tomitaet al., "Mcaf1/am is involved in sp1-mediated maintenance of cancer-associated telomerase activity", Journal of Biological Chemistry, vol. 284, no. 8, p. 5165-5174, 2009. https://doi.org/10.1074/jbc.m807098200[2] A. Minkovsky, A. Sahakyan, E. Rankin-Gee, G. Bonora, S. Patel, & K. Plath, "The mbd1-atf7ip-setdb1 pathway contributes to the maintenance of x chromosome inactivation", Epigenetics & Chromatin, vol. 7, no. 1, 2014. https://doi.org/10.1186/1756-8935-7-12[3] T. Tsusaka, K. Fukuda, C. Shimura, M. Kato, & Y. Shinkai, "The fibronectin type-iii (fniii) domain of atf7ip contributes to efficient transcriptional silencing mediated by the setdb1 complex", Epigenetics & Chromatin, vol. 13, no. 1, 2020. https://doi.org/10.1186/s13072-020-00374-4[4] Y. Li, B. Sun, L. Xu, L. Chen, & W. Ou, "The updating of biological functions of methyltransferase setdb1 and its relevance in lung cancer and mesothelioma", International Journal of Molecular Sciences, vol. 22, no. 14, p. 7416, 2021. https://doi.org/10.3390/ijms22147416[5] N. Sasai, N. Saitoh, H. Saitoh, & M. Nakao, "The transcriptional cofactor mcaf1/atf7ip is involved in histone gene expression and cellular senescence", Plos One, vol. 8, no. 7, p. e68478, 2013. https://doi.org/10.1371/journal.pone.0068478[6] R. Timms, I. Tchasovnikarova, R. Antrobus, G. Dougan, & P. Lehner, "Atf7ip-mediated stabilization of the histone methyltransferase setdb1 is essential for heterochromatin formation by the hush complex", Cell Reports, vol. 17, no. 3, p. 653-659, 2016. https://doi.org/10.1016/j.celrep.2016.09.050[7] J. Sin, C. Zuckerman, J. Cortez, W. Eckalbar, D. Erle, M. Andersonet al., "The epigenetic regulator atf7ip inhibits il2 expression, regulating th17 responses", The Journal of Experimental Medicine, vol. 216, no. 9, p. 2024-2037, 2019. https://doi.org/10.1084/jem.20182316[8] T. Tsusaka, C. Shimura, & Y. Shinkai, "Atf7ip regulates setdb1 nuclear localization and increases its ubiquitination", Embo Reports, vol. 20, no. 12, 2019. https://doi.org/10.15252/embr.201948297[9] Y. Shinkai, T. Tsusaka, K. Fukuda, C. Shimura, & M. Kato, "The fibronectin type-iii (fniii) domain of atf7ip contributes to efficient transcriptional silencing mediated by the setdb1 complex ",, 2020. https://doi.org/10.21203/rs.3.rs-44959/v2[10] T. Tsusaka, M. Kikuchi, T. Shimazu, T. Suzuki, Y. Sohtome, M. Akakabeet al., "Tri-methylation of atf7ip by g9a/glp recruits the chromodomain protein mpp8", Epigenetics & Chromatin, vol. 11, no. 1, 2018. https://doi.org/10.1186/s13072-018-0231-z[11] E. Cornett, L. Ferry, P. Defossez, & S. Rothbart, "Lysine methylation regulators moonlighting outside the epigenome", Molecular Cell, vol. 75, no. 6, p. 1092-1101, 2019. https://doi.org/10.1016/j.molcel.2019.08.026
Activating transcription factor 7-interacting protein 1 (ATF7IP) is a multifunctional protein involved in various cellular processes. It has been shown to interact with methylated DNA-binding domain protein 1 (MBD1) and MBD1-containing chromatin-associated factor 1 (MCAF1), also known as ATFaassociated modulator (AM) [1]. ATF7IP is implicated in the maintenance of X chromosome inactivation (XCI) through its repressive context, where it mediates MBD1-dependent transcriptional silencing by recruiting and catalytically activating the histone H3K9 methyltransferase SETDB1 [2]. Furthermore, ATF7IP contains at least two functional binding surfaces for other proteins, such as SETDB1 and MBD1, and plays a role in efficient transcriptional silencing mediated by the SETDB1 complex [3][4]. It has also been identified as a transcriptional cofactor involved in histone gene expression and cellular senescence [5]. ATF7IP is recognized as a SETDB1-interacting protein and is essential for heterochromatin formation by the HUSH complex [6]. Additionally, ATF7IP has been reported to inhibit Il2 expression, regulating Th17 responses, and is an essential cofactor in SETDB1 enzymatic activity and nuclear localization [7]. Moreover, ATF7IP is involved in the regulation of SETDB1 nuclear localization and its enzymatic activity, as well as in increasing the levels of its ubiquitinated and more enzymatically active forms [8][9]. The protein also undergoes tri-methylation by G9a/GLP, recruiting the chromodomain protein MPP8, suggesting its involvement in gene regulation [10]. Interestingly, ATF7IP’s methylation partially contributes to the function of the HUSH complex, as preventing K16 methylation led to a delay in HUSH complex silencing of a virally introduced transgene [11].
References:[1] L. Liu, K. Ishihara, T. Ichimura, N. Fujita, S. Hino, S. Tomitaet al., “Mcaf1/am is involved in sp1-mediated maintenance of cancer-associated telomerase activity”, Journal of Biological Chemistry, vol. 284, no. 8, p. 5165-5174, 2009. https://doi.org/10.1074/jbc.m807098200[2] A. Minkovsky, A. Sahakyan, E. Rankin-Gee, G. Bonora, S. Patel, & K. Plath, “The mbd1-atf7ip-setdb1 pathway contributes to the maintenance of x chromosome inactivation”, Epigenetics & Chromatin, vol. 7, no. 1, 2014. https://doi.org/10.1186/1756-8935-7-12[3] T. Tsusaka, K. Fukuda, C. Shimura, M. Kato, & Y. Shinkai, “The fibronectin type-iii (fniii) domain of atf7ip contributes to efficient transcriptional silencing mediated by the setdb1 complex”, Epigenetics & Chromatin, vol. 13, no. 1, 2020. https://doi.org/10.1186/s13072-020-00374-4[4] Y. Li, B. Sun, L. Xu, L. Chen, & W. Ou, “The updating of biological functions of methyltransferase setdb1 and its relevance in lung cancer and mesothelioma”, International Journal of Molecular Sciences, vol. 22, no. 14, p. 7416, 2021. https://doi.org/10.3390/ijms22147416[5] N. Sasai, N. Saitoh, H. Saitoh, & M. Nakao, “The transcriptional cofactor mcaf1/atf7ip is involved in histone gene expression and cellular senescence”, Plos One, vol. 8, no. 7, p. e68478, 2013. https://doi.org/10.1371/journal.pone.0068478[6] R. Timms, I. Tchasovnikarova, R. Antrobus, G. Dougan, & P. Lehner, “Atf7ip-mediated stabilization of the histone methyltransferase setdb1 is essential for heterochromatin formation by the hush complex”, Cell Reports, vol. 17, no. 3, p. 653-659, 2016. https://doi.org/10.1016/j.celrep.2016.09.050[7] J. Sin, C. Zuckerman, J. Cortez, W. Eckalbar, D. Erle, M. Andersonet al., “The epigenetic regulator atf7ip inhibits il2 expression, regulating th17 responses”, The Journal of Experimental Medicine, vol. 216, no. 9, p. 2024-2037, 2019. https://doi.org/10.1084/jem.20182316[8] T. Tsusaka, C. Shimura, & Y. Shinkai, “Atf7ip regulates setdb1 nuclear localization and increases its ubiquitination”, Embo Reports, vol. 20, no. 12, 2019. https://doi.org/10.15252/embr.201948297[9] Y. Shinkai, T. Tsusaka, K. Fukuda, C. Shimura, & M. Kato, “The fibronectin type-iii (fniii) domain of atf7ip contributes to efficient transcriptional silencing mediated by the setdb1 complex ”,, 2020. https://doi.org/10.21203/rs.3.rs-44959/v2[10] T. Tsusaka, M. Kikuchi, T. Shimazu, T. Suzuki, Y. Sohtome, M. Akakabeet al., “Tri-methylation of atf7ip by g9a/glp recruits the chromodomain protein mpp8”, Epigenetics & Chromatin, vol. 11, no. 1, 2018. https://doi.org/10.1186/s13072-018-0231-z[11] E. Cornett, L. Ferry, P. Defossez, & S. Rothbart, “Lysine methylation regulators moonlighting outside the epigenome”, Molecular Cell, vol. 75, no. 6, p. 1092-1101, 2019. https://doi.org/10.1016/j.molcel.2019.08.026
| Cat.No | ACP16319 | Target Name | ATF7IP |
|---|---|---|---|
| Form | Lyophilized powder | Expression System | Custom Production. Please inquire and provide the desire expression system. |
| Protein Length | Partial | Purity | >85% (SDS-PAGE) |
| Storage Buffer | 5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0. |
| Target Species | Human | Uniprot ID | Q6VMQ6 |
|---|
Uniprot Id
Q6VMQ6
Target Species
Human
Target Name
ATF7IP
Target Full Name
Activating transcription factor 7-interacting protein 1
Target Function
Recruiter that couples transcriptional factors to general transcription apparatus and thereby modulates transcription regulation and chromatin formation. Can both act as an activator or a repressor depending on the context. Required for HUSH-mediated heterochromatin formation and gene silencing. Mediates MBD1-dependent transcriptional repression, probably by recruiting complexes containing SETDB1. Stabilizes SETDB1, is required to stimulate histone methyltransferase activity of SETDB1 and facilitates the conversion of dimethylated to trimethylated H3 'Lys-9' (H3K9me3). The complex formed with MBD1 and SETDB1 represses transcription and couples DNA methylation and histone H3 'Lys-9' trimethylation (H3K9me3). Facilitates telomerase TERT and TERC gene expression by SP1 in cancer cells
Target Subcellular Location
Nucleus.
Target Protein Families
MCAF family
Target Tissue Specificity
Detected at low levels in breast, lung and stomach; highly up-regulated in the corresponding cancerous tissues (at protein level).
Target Synonyms
ATF7IP; MCAF; MCAF1Activating transcription factor 7-interacting protein 1; ATF-interacting protein; ATF-IP; ATF7-interacting protein; ATFa-associated modulator; hAM; MBD1-containing chromatin-associated factor 1; P621
Notification